Abingdon Health lands £4.8m US diagnostics deal

Abingdon Health has secured a suite of contracts worth  £4.8m with a US-based client to develop and manufacture advanced multiplex diagnostic tests.

The York-headquartered company said the agreements span around 27 months and will cover the full lifecycle of product development—from feasibility and regulatory planning through to large-scale manufacturing. The work will be delivered in milestone-driven packages, with potential for extended collaboration, inclu... You can carry on reading TheBusinessDesk.com for free, but you have reached the maximum number of pages an unregistered user can view. To register for an account, click here or login below...